The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.
暂无分享,去创建一个
[1] G. Marchesini,et al. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[2] A. Lonardo,et al. The independent predictors of non‐alcoholic steatohepatitis and its individual histological features. , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.
[3] Corrado Barbui,et al. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. , 2016, Journal of hepatology.
[4] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[5] F. Piscaglia,et al. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study , 2016, Hepatology.
[6] A. Lonardo,et al. The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans , 2016, Advances in Therapy.
[7] A. Hofman,et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study , 2016, Hepatology.
[8] L. Henry,et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 , 2015, Hepatology.
[9] L. Henry,et al. Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease , 2015, PharmacoEconomics.
[10] E. Bjornsson,et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. , 2015, Gastroenterology.
[11] Mary E Rinella,et al. Nonalcoholic fatty liver disease: a systematic review. , 2015, JAMA.
[12] Mats Fredrikson,et al. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.
[13] A. Burt,et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. , 2015, Journal of hepatology.
[14] V. Ratziu,et al. Non-alcoholic fatty liver - perhaps not so benign. , 2015, Journal of hepatology.
[15] Zhen Wang,et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] Aijaz Ahmed,et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.
[17] K. Cusi,et al. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. , 2014, The Journal of clinical endocrinology and metabolism.
[18] J. Jónasson,et al. Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease , 2014, BMC Gastroenterology.
[19] P. Nilsson,et al. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD , 2014, Scandinavian journal of gastroenterology.
[20] A. McCullough,et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non‐alcoholic fatty liver disease , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[21] J. Marrero,et al. The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis , 2014, The American Journal of Gastroenterology.
[22] A. Diehl,et al. NAFLD, NASH and liver cancer , 2013, Nature Reviews Gastroenterology &Hepatology.
[23] L. Beilin,et al. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents , 2013, Hepatology.
[24] P. Bedossa,et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. , 2013, Journal of hepatology.
[25] K. Goh,et al. Non‐alcoholic fatty liver disease in diabetics – prevalence and predictive factors in a multiracial hospital clinic population in Malaysia , 2013, Journal of gastroenterology and hepatology.
[26] H. Makhlouf,et al. Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) , 2013, Digestive Diseases and Sciences.
[27] A. Lonardo,et al. Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? , 2013, Internal and Emergency Medicine.
[28] Miriam B. Vos,et al. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. , 2013, The Journal of pediatrics.
[29] C. Renou,et al. A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France. , 2012, Journal of hepatology.
[30] A. Craxì,et al. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. , 2012, Journal of hepatology.
[31] Michael Charlton,et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. , 2012, Gastroenterology.
[32] Z. Halpern,et al. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. , 2012, Journal of hepatology.
[33] Y. Lim,et al. Colorectal neoplasms in relation to non‐alcoholic fatty liver disease in Korean women: A retrospective cohort study , 2012, Journal of gastroenterology and hepatology.
[34] Giorgio Saracco,et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study , 2011, Hepatology.
[35] A. Craxì,et al. Hyperuricemia is associated with histological liver damage in patients with non‐alcoholic fatty liver disease , 2011, Alimentary pharmacology & therapeutics.
[36] J. Heimbach,et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. , 2011, Gastroenterology.
[37] A. Baranova,et al. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non‐alcoholic fatty liver disease , 2011, Alimentary pharmacology & therapeutics.
[38] L. Beilin,et al. Gender‐specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease , 2011, Hepatology.
[39] B. Neuschwander‐Tetri,et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.
[40] Vincent Wai-Sun Wong,et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years , 2010, Gut.
[41] J. Ahmad,et al. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[42] Greger Lindberg,et al. Decreased survival of subjects with elevated liver function tests during a 28‐year follow‐up , 2010, Hepatology.
[43] P. Fontes,et al. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[44] A. Lonardo,et al. Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[45] S. Caldwell,et al. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. , 2009, Journal of hepatology.
[46] M. Zoli,et al. Hepatocellular carcinoma in patients with cryptogenic cirrhosis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[47] V. Paradis,et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis , 2009, Hepatology.
[48] Chunhong Bai,et al. Long-term follow-up of patients with nonalcoholic fatty liver. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[49] Z. Younossi,et al. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. , 2008, Journal of hepatology.
[50] R. Xu,et al. Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study , 2008, The American Journal of Gastroenterology.
[51] S. Czernichow,et al. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. , 2008, Journal of hepatology.
[52] M. Holmqvist,et al. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.
[53] Robert A Fisher,et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C , 2006, Hepatology.
[54] C. Nievergelt,et al. Histopathology of pediatric nonalcoholic fatty liver disease , 2005, Hepatology.
[55] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[56] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[57] N. Chalasani,et al. Unexplained Elevations in Alanine Aminotransferase in Individuals with the Metabolic Syndrome: Results from the Third National Health and Nutrition Survey (NHANES III) , 2005, The American journal of the medical sciences.
[58] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[59] A. McCullough,et al. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.
[60] N. Chalasani,et al. Is Hypothyroidism a Risk Factor for Non-Alcoholic Steatohepatitis? , 2003, Journal of clinical gastroenterology.
[61] James G Kench,et al. Long‐term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C , 2003, Hepatology.
[62] Mauro Salizzoni,et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. , 2002, Gastroenterology.
[63] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[64] Z. Younossi,et al. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[65] J. Dixon,et al. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.
[66] P. Thuluvath,et al. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study , 2000, Hepatology.
[67] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[68] S. Caldwell,et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.
[69] W. Kim,et al. Recurrence of nonalcoholic steatohepatitis following liver transplantation. , 1996, Transplantation.
[70] M. Bennett,et al. The natural history of nonalcoholic fatty liver: A follow‐up study , 1995, Hepatology.
[71] R. Hanson,et al. The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.
[72] JunyongPark,et al. Factors associated with significant liver fibrosis assessed using transient elastography in general population , 2015 .
[73] Brian P. Mulhall,et al. Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.
[74] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.
[75] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.